Detection rates of anti-cyclic citrullinated peptide (anti-CCP and anti-MCV) antibodies in patients with juvenile idiopathic arthritis and clinical characteristics of seropositive patients
- Authors: Shilova T.1, Pishchalnikov A.1, Volosnikov D.1, Serebryakova E.1
-
Affiliations:
- South Ural State Medical University
- Issue: Vol 29, No 5 (2018)
- Pages: 64-66
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/117246
- DOI: https://doi.org/10.29296/25877305-2018-05-16
- ID: 117246
Cite item
Abstract
The paper provides data on the detection rates of antibodies against anti-cyclic citrullinated peptide (anti-CCP) and modified citrullinated vimentin (anti-MCV) in children with juvenile idiopathic arthritis and gives the clinical characteristics of seropositive patients. By and large, anti-CCP antibodies were found in 25.4% of cases. At the time of examination more than 70% of patients seropositive for anti-CCP and anti-MCV developed symmetric polyarthritis, regardless of the type of disease onset.
Full Text
About the authors
T. Shilova
South Ural State Medical University
Email: tanya920477@mail.ru
Candidate of Medical Sciences Chelyabinsk
A. Pishchalnikov
South Ural State Medical University
Email: tanya920477@mail.ru
MD Chelyabinsk
D. Volosnikov
South Ural State Medical University
Email: tanya920477@mail.ru
MD Chelyabinsk
E. Serebryakova
South Ural State Medical University
Email: tanya920477@mail.ru
Candidate of Medical Sciences Chelyabinsk
References
- Алексеева Е.И., Литвицкий П.Ф. Ювенильный ревматоидный артрит: этиология, патогенез, клиника, алгоритмы диагностики и лечения: Руководство для врачей, преподавателей, научных сотрудников. Под общей ред. А.А. Баранова / М.: ВЕДИ, 2007; 368 с.
- Ki Hwan Kim, Dong Soo Kim. Juvenile idiopathic arthritis: Diagnosis and differential diagnosis // Korean J. Pediatr. - 2010; 53 (11): 931-5.
- Petty R., Southwood T., Baum J. et al. Revision of the Proposed Classification Criteria for juvenile idiopathic arthritis. Durban, 1997 // J. Rheumat. - 1998; 25 (10): 1991-4.
- Лапин С.В., Тотолян А.А. Иммунологическая лабораторная диагностика ревматических заболеваний: пособие для врачей / СПб: Издательство «Человек», 2006; 128 с.
- Салугина С.О., Федоров Е.С., Александрова Е.Н. и др. Клиническое и диагностическое значение антител к циклическому цитруллинированному пептиду при раннем ювенильном артрите // Современная ревматология. -2009; 2: 24-8.
- Avcin T., Cimaz R., Falcini F. et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis // Ann. Rheum. Dis. - 2002; 61 (7): 608-11.
- Ghaffarpasand F. Anticyclic citrullinated peptide antibody: a predictor of juvenile idiopathic arthritis progression toward rheumatoid arthritis // J. Med. Diagn. Methods. - 2012; 1 (1): 1-2.
- Snir O., Widhe M., Hermansson M. et al. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients // Arthritis & Rheumatism. - 2010; 62 (1): 44-52.
- Hofer M., Southwood T. Evaluation of the ILAR classification for juvenile idiopathic arthritis: a meta - analysis // EULAR. - 2002; SAT0224.